{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T23:20:34Z","timestamp":1794784834869,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Province","doi-asserted-by":"publisher","award":["25JR062"],"award-info":[{"award-number":["25JR062"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474348"],"award-info":[{"award-number":["82474348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hand Surgery and Rehabilitation"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hansur.2026.102762","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T15:21:31Z","timestamp":1787412091000},"page":"102762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease-modifying antirheumatic drugs for hand osteoarthritis: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"45","author":[{"given":"Pei","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianle","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puwei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10472","key":"10.1016\/j.hansur.2026.102762_bib0005","first-page":"71","article-title":"Lancet","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Osteoarthritis"},{"issue":"1","key":"10.1016\/j.hansur.2026.102762_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.hansur.2026.102762_bib0015","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.joca.2025.08.015","article-title":"Osteoarthritis year in review 2025: epidemiology and therapy","volume":"33","author":"Dell\u2019Isola","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.hansur.2026.102762_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41584-021-00747-3","article-title":"Erosive hand osteoarthritis: latest findings and outlook","volume":"18","author":"Favero","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"10414","key":"10.1016\/j.hansur.2026.102762_bib0025","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(23)01572-6","article-title":"Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial","volume":"402","author":"Wang","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.hansur.2026.102762_bib0030","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2018-213202","article-title":"Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"77","author":"Kloppenburg","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.hansur.2026.102762_bib0035","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.semarthrit.2021.04.016","article-title":"Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial","volume":"51","author":"Ferrero","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.hansur.2026.102762_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/annrheumdis-2018-213826","article-title":"2018 update of the EULAR recommendations for the management of hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.hansur.2026.102762_bib0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.hansur.2026.102762_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105444","article-title":"Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: a meta-analysis","volume":"89","author":"Mathieu","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.hansur.2026.102762_bib0055","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/rheumatology\/key131","article-title":"Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials","volume":"57","author":"Persson","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.hansur.2026.102762_bib0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.joca.2025.02.786","article-title":"Efficacy and safety of methotrexate in osteoarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Wong","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.hansur.2026.102762_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3904\/kjim.2020.605","article-title":"Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Singh","year":"2022","journal-title":"Korean J Intern Med"},{"issue":"11","key":"10.1016\/j.hansur.2026.102762_bib0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hansur.2026.102762_bib0075","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.hansur.2026.102762_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.hansur.2026.102762_bib0085","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/annrheumdis-2014-205348","article-title":"French section of osteoarthritis. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial","volume":"74","author":"Chevalier","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.hansur.2026.102762_bib0090","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/S2665-9913(20)30171-5","article-title":"Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial","volume":"2","author":"Schett","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"10.1016\/j.hansur.2026.102762_bib0095","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.23471","article-title":"Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Lee","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.hansur.2026.102762_bib0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2020-218547","article-title":"Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial","volume":"80","author":"Richette","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.hansur.2026.102762_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001660","article-title":"Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial","volume":"7","author":"Kedor","year":"2021","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.hansur.2026.102762_bib0110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","article-title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1\u03b1 and anti-interleukin-1\u03b2 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.hansur.2026.102762_bib0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.7326\/M17-1430","article-title":"Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis: a randomized trial","volume":"168","author":"Kingsbury","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.hansur.2026.102762_bib0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","article-title":"A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial","volume":"26","author":"Aitken","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"10.1016\/j.hansur.2026.102762_bib0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/ard.2011.149849","article-title":"Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification","volume":"71","author":"Verbruggen","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.hansur.2026.102762_bib0130","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004963","article-title":"Efficacy and safety of non-pharmacological, pharmacological and surgical treatments for hand osteoarthritis in 2024: a systematic review","volume":"11","author":"Kjeken","year":"2025","journal-title":"RMD Open"},{"issue":"10213","key":"10.1016\/j.hansur.2026.102762_bib0135","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(19)32489-4","article-title":"Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial","volume":"394","author":"Kroon","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hansur.2026.102762_bib0140","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41591-024-02822-0","article-title":"RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial","volume":"30","author":"Wittoek","year":"2024","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.hansur.2026.102762_bib0145","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.joca.2024.04.011","article-title":"Hand osteoarthritis phenotypes based on a biopsychosocial approach, and their associations with cross-sectional and longitudinal pain","volume":"32","author":"Mulrooney","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"10.1016\/j.hansur.2026.102762_bib0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.joca.2021.03.018","article-title":"Synovitis and bone marrow lesions associate with symptoms and radiographic progression in hand osteoarthritis: a systematic review and meta-analysis of observational studies","volume":"29","author":"Obotiba","year":"2021","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Hand Surgery and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468122926001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468122926001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:58:25Z","timestamp":1794783505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468122926001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2468122926001994"],"URL":"https:\/\/doi.org\/10.1016\/j.hansur.2026.102762","relation":{},"ISSN":["2468-1229"],"issn-type":[{"value":"2468-1229","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-modifying antirheumatic drugs for hand osteoarthritis: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Hand Surgery and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hansur.2026.102762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of SFCM.","name":"copyright","label":"Copyright"}],"article-number":"102762"}}